Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies. | Int J Mol Sci | 2022 | 35628381 | PubTator, text mining | PubMed |
| Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment. | Diagnostics (Basel) | 2022 | 35626243 | PubTator, text mining | PubMed |
| Dysregulation and therapeutic targeting of RNA splicing in cancer. | Nat Cancer | 2022 | 35624337 | PubTator, text mining | PubMed |
| Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases. | Cell Biosci | 2022 | 35619184 | PubTator, text mining | PubMed |
| A rock in the toll road: IRAK4 inhibition of TLR4-MyD88 signaling as potential treatment for addiction. | Brain Behav Immun | 2022 | 35618228 | PubTator, text mining | PubMed |
| Acinetobacter baumannii Secretes a Bioactive Lipid That Triggers Inflammatory Signaling and Cell Death. | Front Microbiol | 2022 | 35615509 | PubTator, text mining | PubMed |
| Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. | J Hematol Oncol | 2022 | 35606824 | PubTator, text mining | PubMed |
| Helicobacter pylori promotes inflammatory factor secretion and lung injury through VacA exotoxin-mediated activation of NF-κB signaling. | Bioengineered | 2022 | 35603777 | PubTator, text mining | PubMed |
| Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations. | Front Pediatr | 2022 | 35601409 | PubTator, text mining | PubMed |
| The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers. | Integr Cancer Ther | 2022 | 35593403 | PubTator, text mining | PubMed |
| Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation. | Lung Cancer (Auckl) | 2022 | 35592355 | PubTator, text mining | PubMed |
| Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents. | J Enzyme Inhib Med Chem | 2022 | 35589670 | PubTator, text mining | PubMed |
| Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming. | Cell Mol Life Sci | 2022 | 35588018 | PubTator, text mining | PubMed |
| EB1089 promotes the expression of vitamin D receptor in the intestinal epithelial cell line HT-29 and reduces lipopolysaccharide-induced inflammatory response. | Ann Transl Med | 2022 | 35571391 | PubTator, text mining | PubMed |
| Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. | Clin Cancer Res | 2022 | 35552677 | PubTator, text mining | PubMed |
| In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis. | Evid Based Complement Alternat Med | 2022 | 35535159 | PubTator, text mining | PubMed |
| Structural analysis of receptor-like kinase SOBIR1 reveals mechanisms that regulate its phosphorylation-dependent activation. | Plant Commun | 2022 | 35529948 | PubTator, text mining | PubMed |
| Purification, crystallization and drug screening of the IRAK pseudokinases. | Methods Enzymol | 2022 | 35525539 | PubTator, text mining | PubMed |
| Role of Toll-Like Receptors and Th Responses in Viral Myocarditis. | Front Immunol | 2022 | 35514979 | PubTator, text mining | PubMed |
| A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a 14 C-Microtracer Approach. | Clin Pharmacol Drug Dev | 2022 | 35506501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=42